Testing COVID-19 therapies to prevent progression of mild disease.
作者信息
Lipsitch Marc, Perlman Stanley, Waldor Matthew K
机构信息
Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Department of Microbiology and Immunology and Department of Pediatrics, University of Iowa, Iowa City, IA, USA.
出版信息
Lancet Infect Dis. 2020 Dec;20(12):1367. doi: 10.1016/S1473-3099(20)30372-8. Epub 2020 May 6.
Abstract
摘要
相似文献
1
Testing COVID-19 therapies to prevent progression of mild disease.测试新冠病毒疾病疗法以预防轻症进展。
Lancet Infect Dis. 2020 Dec;20(12):1367. doi: 10.1016/S1473-3099(20)30372-8. Epub 2020 May 6.
2
Re: Testing recommendation for COVID-19 and planned surgery.
Br J Oral Maxillofac Surg. 2020 Sep;58(7):876-877. doi: 10.1016/j.bjoms.2020.04.052. Epub 2020 Jun 28.
3
Contamination of personal protective equipment by SARS-CoV-2 during routine care of patients with mild COVID-19.在对轻度新冠肺炎患者进行常规护理期间，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）对个人防护装备造成的污染
J Infect. 2020 Aug;81(2):e165-e167. doi: 10.1016/j.jinf.2020.06.021. Epub 2020 Jun 12.
4
Compassion, resilience and COVID-19.同情、适应力与新冠疫情
J R Coll Physicians Edinb. 2020 Jun;50(2):105-106. doi: 10.4997/JRCPE.2020.203.
5
Cell-Free Therapies: Novel Approaches for COVID-19.无细胞疗法：治疗新冠肺炎的新方法。
Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.
6
Re: Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic.关于：为计划进行手术的患者进行新冠病毒（SARS-CoV-2）检测的建议——持续服务并“抑制”疫情。
Br J Oral Maxillofac Surg. 2020 Sep;58(7):872. doi: 10.1016/j.bjoms.2020.05.005. Epub 2020 May 11.
7
High COVID-19 testing rate in Portugal.葡萄牙新冠病毒检测率高。
Lancet Infect Dis. 2020 Jul;20(7):783. doi: 10.1016/S1473-3099(20)30499-0.
8
[COVID-19 and Pulmonology: New Challenges and Opportunities].[新型冠状病毒肺炎与肺病学：新挑战与新机遇]
Acta Med Port. 2020 Oct 1;33(10):710. doi: 10.20344/amp.14760. Epub 2020 Sep 2.
9
COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.新冠病毒病（COVID-19）：确诊感染新冠病毒病后再次入院患者的治疗结果
J Infect. 2020 Sep;81(3):e18-e19. doi: 10.1016/j.jinf.2020.07.007. Epub 2020 Jul 8.
10
COVID-19-a very visible pandemic.新冠病毒病——一场非常引人注目的大流行病。
Lancet. 2020 Aug 8;396(10248):e18. doi: 10.1016/S0140-6736(20)31676-7.
引用本文的文献
1
Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2.佩米替尼通过阻断病毒刺突蛋白与 ACE2 之间的相互作用来抑制 SARS-CoV-2 的变体进入细胞。
J Food Biochem. 2022 Oct;46(10):e14354. doi: 10.1111/jfbc.14354. Epub 2022 Jul 27.
2
Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19.目前用于治疗 COVID-19 的临床药物疗法和生物制剂，包括正在临床试验中的药物。
Biomed Pharmacother. 2021 Dec;144:112276. doi: 10.1016/j.biopha.2021.112276. Epub 2021 Oct 2.
3
A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials.一种计算方法，帮助临床医生在 COVID-19 试验中选择抗病毒药物。
Sci Rep. 2021 Apr 27;11(1):9047. doi: 10.1038/s41598-021-88153-3.
4
All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study.墨西哥城使用重新利用的抗病毒药物和抗生素治疗新冠肺炎患者的全因死亡率：一项真实世界观察性研究。
EXCLI J. 2021 Feb 4;20:199-222. doi: 10.17179/excli2021-3413. eCollection 2021.
5
Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study.清肺排毒汤早期治疗对 COVID-19 患者临床结局的影响：一项回顾性多中心队列研究。
Pharmacol Res. 2020 Nov;161:105290. doi: 10.1016/j.phrs.2020.105290. Epub 2020 Nov 9.
6
Assessing the spreading potential of an undetected case of COVID-19 in orthopaedic surgery.评估骨科手术中未被发现的 COVID-19 病例的传播潜力。
Arch Orthop Trauma Surg. 2021 Jul;141(7):1131-1137. doi: 10.1007/s00402-020-03516-1. Epub 2020 Jun 10.
本文引用的文献
1
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.预测 SARS-CoV-2 的传播动力学，直至大流行后期。
Science. 2020 May 22;368(6493):860-868. doi: 10.1126/science.abb5793. Epub 2020 Apr 14.
2
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征：一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.
3
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.巴洛沙韦玛波西利治疗成人和青少年单纯性流感。
N Engl J Med. 2018 Sep 6;379(10):913-923. doi: 10.1056/NEJMoa1716197.
Zotero 插件